The MC4R SNPs, their haplotypes and gene-environment interactions on the risk of obesity.


Journal

Molecular medicine (Cambridge, Mass.)
ISSN: 1528-3658
Titre abrégé: Mol Med
Pays: England
ID NLM: 9501023

Informations de publication

Date de publication:
08 08 2020
Historique:
received: 17 04 2020
accepted: 21 07 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 11 8 2021
Statut: epublish

Résumé

Little is known about the correlation between the melanocortin 4 receptor gene (MC4R) single nucleotide polymorphisms (SNPs) and the risk of obesity. This research sought to test the MC4R rs17782313, rs476828 and rs12970134 SNPs, their haplotypes and gene-environment interactions on the risk of obesity in the Maonan ethnic group, an isolated minority in China. A case-control study comprised of 1836 participants (obesity group, 858; and control group, 978) was conducted. Genotypes of the three SNPs were determined by the next-generation sequencing (NGS) technology. The genotypic frequencies of the three SNPs were different between the obesity and control groups (P <  0.05 for all). The minor allelic frequency of the MC4R rs17782313C, rs476828C and rs12970134A was higher in obesity than in control groups (13.8% vs. 8.3%, P <  0.001, 17.1% vs. 10.9%, P <  0.001; and 15.5% vs. 11.5%, P <  0.001; respectively). Additionally, the dominant model of rs17782313 and rs476828 SNPs revealed an increased morbidity function on the risk of obesity (P <  0.05). A correlation between SNP-environment and the risk of obesity was also observed. The rs17782313C-rs476828C-rs12970134A haplotype was associated with high risk of obesity (OR = 1.796, 95% CI = 1.447-2.229), whereas the rs17782313T-rs476828T-rs12970134G and rs17782313T-rs476828T-rs12970134A haplotypes were associated with low risk of obesity (OR = 0.699, 95% CI = 0.586-0.834 and OR = 0.620, 95% CI = 0.416-0.925; respectively). The interactions between haplotype and waist circumference on the risk of obesity were also noted. We discovered that the MC4R rs17782313, rs476828 and rs12970134 SNPs and their haplotypes were associated with the risk of obesity in the Chinese Maonan population.

Sections du résumé

BACKGROUND
Little is known about the correlation between the melanocortin 4 receptor gene (MC4R) single nucleotide polymorphisms (SNPs) and the risk of obesity. This research sought to test the MC4R rs17782313, rs476828 and rs12970134 SNPs, their haplotypes and gene-environment interactions on the risk of obesity in the Maonan ethnic group, an isolated minority in China.
METHODS
A case-control study comprised of 1836 participants (obesity group, 858; and control group, 978) was conducted. Genotypes of the three SNPs were determined by the next-generation sequencing (NGS) technology.
RESULTS
The genotypic frequencies of the three SNPs were different between the obesity and control groups (P <  0.05 for all). The minor allelic frequency of the MC4R rs17782313C, rs476828C and rs12970134A was higher in obesity than in control groups (13.8% vs. 8.3%, P <  0.001, 17.1% vs. 10.9%, P <  0.001; and 15.5% vs. 11.5%, P <  0.001; respectively). Additionally, the dominant model of rs17782313 and rs476828 SNPs revealed an increased morbidity function on the risk of obesity (P <  0.05). A correlation between SNP-environment and the risk of obesity was also observed. The rs17782313C-rs476828C-rs12970134A haplotype was associated with high risk of obesity (OR = 1.796, 95% CI = 1.447-2.229), whereas the rs17782313T-rs476828T-rs12970134G and rs17782313T-rs476828T-rs12970134A haplotypes were associated with low risk of obesity (OR = 0.699, 95% CI = 0.586-0.834 and OR = 0.620, 95% CI = 0.416-0.925; respectively). The interactions between haplotype and waist circumference on the risk of obesity were also noted.
CONCLUSIONS
We discovered that the MC4R rs17782313, rs476828 and rs12970134 SNPs and their haplotypes were associated with the risk of obesity in the Chinese Maonan population.

Identifiants

pubmed: 32770936
doi: 10.1186/s10020-020-00202-1
pii: 10.1186/s10020-020-00202-1
pmc: PMC7414557
doi:

Substances chimiques

Biomarkers 0
MC4R protein, human 0
Receptor, Melanocortin, Type 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Références

Mol Biol Rep. 2012 Jun;39(6):6487-93
pubmed: 22350153
Diabetes. 2010 Dec;59(12):3085-9
pubmed: 20843981
Obes Facts. 2011;4(1):67-75
pubmed: 21372613
Diabetes Care. 2006 Apr;29(4):901-7
pubmed: 16567835
Heredity (Edinb). 2015 Mar;114(3):255-61
pubmed: 25335557
J Am Diet Assoc. 2008 Jun;108(6):970-6
pubmed: 18502227
J Cell Mol Med. 2014 Jul;18(7):1417-28
pubmed: 24780069
Obesity (Silver Spring). 2009 Jul;17(7):1461-5
pubmed: 19265794
Nat Genet. 2009 Jan;41(1):18-24
pubmed: 19079260
BMC Med Genet. 2019 Aug 20;20(1):144
pubmed: 31429705
J Clin Endocrinol Metab. 2012 Jun;97(6):E1074-9
pubmed: 22466342
Curr Opin Cardiol. 2006 Jan;21(1):1-6
pubmed: 16355022
Int J Obes (Lond). 2009 Nov;33(11):1243-8
pubmed: 19668254
J Clin Endocrinol Metab. 2010 Mar;95(3):1395-403
pubmed: 20061430
Metabolism. 2019 Mar;92:6-10
pubmed: 30253139
J Hum Genet. 2009 Dec;54(12):727-31
pubmed: 19851340
Crit Rev Eukaryot Gene Expr. 2016;26(3):187-98
pubmed: 27650984
Nat Genet. 2008 Jun;40(6):768-75
pubmed: 18454148
Mol Cell Endocrinol. 2010 Mar 25;316(2):104-8
pubmed: 19628019
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Jul;25(7):623-6
pubmed: 15308047
Obes Rev. 2012 Feb;13(2):174-91
pubmed: 22060052
Tissue Antigens. 2009 Jun;73(6):575-81
pubmed: 19392802
Diabetes. 2009 Mar;58(3):757-64
pubmed: 19073769
Hum Reprod. 2012 Aug;27(8):2484-93
pubmed: 22674204
PLoS Genet. 2016 May 12;12(5):e1006065
pubmed: 27171145
Am J Hum Genet. 2007 Jun;80(6):1125-37
pubmed: 17503330
Am J Clin Nutr. 1985 Aug;42(2):289-95
pubmed: 4025199
Nutr Rev. 2011 Aug;69(8):419-31
pubmed: 21790610
Curr Genomics. 2016 Oct;17(5):396-402
pubmed: 28479868
Nat Genet. 2009 Jan;41(1):25-34
pubmed: 19079261
Nat Genet. 2009 Feb;41(2):157-9
pubmed: 19151714
J Clin Endocrinol Metab. 2010 May;95(5):2418-25
pubmed: 20215397
Cell Res. 2005 Feb;15(2):97-8
pubmed: 15740637
Nature. 2011 Jul 13;475(7355):176-7
pubmed: 21753841
Clin Pharmacol Ther. 2011 Jul;90(1):164-8
pubmed: 21633341
J Mol Med (Berl). 2009 May;87(5):537-46
pubmed: 19255736
J Cell Mol Med. 2016 Feb;20(2):243-65
pubmed: 26493351
J Nutr Biochem. 2012 Sep;23(9):1027-40
pubmed: 22749135
Nutr Rev. 2013 Feb;71(2):67-87
pubmed: 23356635
J Genet Genomics. 2007 Dec;34(12):1072-9
pubmed: 18155619
J Adolesc Health. 2003 Apr;32(4):306-13
pubmed: 12667735
Ann Epidemiol. 2018 Mar;28(3):175-181.e4
pubmed: 29402536
Am J Clin Nutr. 2010 Feb;91(2):321-8
pubmed: 20007308
PLoS One. 2013 Sep 17;8(9):e74264
pubmed: 24069289
Sci Rep. 2018 Apr 18;8(1):6189
pubmed: 29670124
Endocrine. 2011 Feb;39(1):69-74
pubmed: 21063808
Nutrients. 2016 Apr 08;8(4):208
pubmed: 27070640
Eur Heart J. 2018 May 1;39(17):1532-1534
pubmed: 29529292
Mol Genet Metab. 2011 May;103(1):71-5
pubmed: 21303735
Lipids Health Dis. 2018 Feb 17;17(1):30
pubmed: 29454388
Hum Mol Genet. 2009 Apr 15;18(8):1489-96
pubmed: 19164386
Eur J Clin Invest. 2018 Sep;48(9):e12997
pubmed: 29995306
Ann Intern Med. 2003 Jan 7;138(1):24-32
pubmed: 12513041
Am J Epidemiol. 2010 Aug 1;172(3):244-54
pubmed: 20616199
Lipids Health Dis. 2017 Jan 5;16(1):1
pubmed: 28056980
Obesity (Silver Spring). 2012 Feb;20(2):389-95
pubmed: 21720444
Tissue Antigens. 2007 Feb;69(2):154-60
pubmed: 17257318
Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):1009-60
pubmed: 10423121
Public Health Nutr. 2009 Apr;12(4):497-506
pubmed: 18547457
Am J Epidemiol. 2011 Jun 1;173(11):1256-62
pubmed: 21527513

Auteurs

Bi-Liu Wei (BL)

Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.

Rui-Xing Yin (RX)

Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China. yinruixing@163.com.
Guangxi Key Laboratory Base of Precision Medicine in Cardio-cerebrovascular Disease Control and Prevention, Nanning, Guangxi, 530021, People's Republic of China. yinruixing@163.com.
Guangxi Clinical Research Center for Cardio-cerebrovascular Diseases, Nanning, Guangxi, 530021, People's Republic of China. yinruixing@163.com.

Chun-Xiao Liu (CX)

Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.

Guo-Xiong Deng (GX)

Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.

Yao-Zong Guan (YZ)

Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.

Peng-Fei Zheng (PF)

Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University, 6 Shuangyong Road, Nanning, Guangxi, 530021, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH